ClinVar Miner

Submissions for variant NM_000038.6(APC):c.3786T>C (p.Tyr1262=)

gnomAD frequency: 0.00009  dbSNP: rs147411334
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003534465 SCV000252920 likely benign Familial adenomatous polyposis 1 2024-01-31 criteria provided, single submitter clinical testing
GeneDx RCV000423289 SCV000512072 benign not specified 2015-06-08 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000491700 SCV000579794 likely benign Hereditary cancer-predisposing syndrome 2014-11-19 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001800523 SCV000600089 benign not provided 2020-12-24 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000491700 SCV000681633 likely benign Hereditary cancer-predisposing syndrome 2016-12-13 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000423289 SCV001361425 benign not specified 2019-01-29 criteria provided, single submitter clinical testing Variant summary: APC c.3786T>C alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 9e-05 in 276270 control chromosomes (gnomAD). The observed variant frequency is approximately 1.27 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis phenotype (7.1e-05), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3786T>C in individuals affected with Familial Adenomatous Polyposis and no experimental evidence demonstrating its impact on protein function have been reported. Four ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cites the variant as likely benign/benign. Based on the evidence outlined above, the variant was classified as benign.
Sema4, Sema4 RCV000491700 SCV002533925 likely benign Hereditary cancer-predisposing syndrome 2021-09-04 criteria provided, single submitter curation
CeGaT Center for Human Genetics Tuebingen RCV001800523 SCV004042231 likely benign not provided 2023-09-01 criteria provided, single submitter clinical testing APC: BP4, BP7
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000423289 SCV004243239 likely benign not specified 2024-02-06 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001354708 SCV001549390 likely benign Carcinoma of colon no assertion criteria provided clinical testing The APC p.Tyr1262= variant was not identified in the literature nor was it identified in the GeneInsight-COGR, Cosmic, MutDB, LOVD 3.0, UMD-LSDB or Zhejiang Colon Cancer Database. The variant was identified in dbSNP (ID: rs147411334) “With Likely benign allele”, ClinVar (classified benign by GeneDx, and likely benign by Invitae, Ambry Genetics, Color Genomics Inc. and Quest Diagnostics Nichols Institute San Juan Capistrano), Clinvitae (3x), and in control databases in 25 of 276270 chromosomes at a frequency of 0.00009 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 1 of 24002 chromosomes (freq: 0.00004), Other in 3 of 6446 chromosomes (freq: 0.0005), Latino in 5 of 34372 chromosomes (freq: 0.0001), European Non-Finnish in 14 of 125934 chromosomes (freq: 0.0001), European Finnish in 1 of 25772 chromosomes (freq: 0.00004), and South Asian in 1 of 30756 chromosomes (freq: 0.00003) while not observed in the Ashkenazi Jewish and East Asian populations. The p.Tyr1262= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.